Tesofensine, due to its central nervous system activity, warrants careful consideration of potential neurological or cardiovascular effects, as seen in some historical trial data
The Vote and What It Means Despite internal objections from agency scientists, the PCAC voted 8-6 in favor of recommending BPC-157 for inclusion, specifically for use in treating ulcerative colitis
Here are a few reasons patients might go for an oral semaglutide experience: Theyre already taking other oral medications and like the consistency They travel often and want something more discreet They dislike injections or have trouble using injectable pens They feel more in control with a semaglutide pill vs injection The bottom line
While effective, the requirement for weekly injections has been a barrier for many patients
Assessing what matters most to patients with or at risk for Alzheimers and care partners: A qualitative study evaluating symptoms, impacts, and outcomes